The Contradictory Effects of SPTLC1 on Clear Cell Renal Carcinoma Sensitivity to Sunitinib Mediated by Androgen Receptor
Molecular Carcinogenesis · 2025
DOI: 10.1002/mc.70023 ↗At a glance
Journal article in Molecular Carcinogenesis, 2025. Written by Liqiong Liao and 9 co-authors. Institution: Guangdong Provincial Key Laboratory of Urological Diseases, Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital o…. Major MEDLINE topics: Carcinoma, Renal Cell, Sunitinib, Kidney Neoplasms, Receptors, Androgen. 40 references. Funded by: This study was financed by grants from the Characteristic Innovation project of Guangdong Province Education Department (2019KTSCX140), the Scientific research….
Abstract (original language)
Serine palmitoyltransferase long chain‐1 (SPTLC1) is a key enzyme in ceramide synthesis, previously identified as a suppressor of tumorigenesis in clear cell renal carcinoma (ccRCC). Although elevated levels of very long‐chain ceramides are associated with the canonical multidrug resistance in ccRCC, the specific role of SPTLC1 in modulating the sensitivity of ccRCC to sunitinib remains unclear. In this study, we found that SPTLC1 overexpression could enhance the sensitivities of 786‐O and OSRC‐2 cells to sunitinib via downregulating CerS2 expression and long‐chain ceramide levels. In contrast, SPTLC1 upregulated CerS2 expression and long‐chain ceramide levels in A498 cells, yet without a significant impact on its sensitivity to sunitinib. In addition, overexpression of CerS2 significantly attenuated SPTLC1‐enhanced sensitivities of 786‐O and OSRC‐2 cells to sunitinib, whereas CerS2 knockdown obviously enhanced the sensitivity of A498 cells to sunitinib. Moreover, androgen receptor (AR) expression was significantly decreased in SPTLC1‐overexpressed 786‐O cells and forced AR expression could obviously attenuate the downregulation of CerS2 expression induced by SPTLC1 in 786‐O cells, whereas opposite results were observed in A498 cells, suggesting that the contradictory effects of SPTLC1 on CerS2 expression were modulated by AR. Taken together, our results demonstrated that the contradictory effects of SPTLC1 on clear cell renal carcinoma sensitivity to sunitinib were caused by AR‐mediated CerS2 expression, thus revealing a novel role and mechanism of SPTLC1 in the regulation of ccRCC sensitivity to sunitinib.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Guangdong Provincial Key Laboratory of Urological Diseases, Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Urology, Guangz…
- Department of Pharmacy, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
- Department of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
ORCID profiles: Liqiong Liao, Xiaolu Duan
Funding
- This study was financed by grants from the Characteristic Innovation project of Guangdong Province Education Department (2019KTSCX140), the Scientific research…
Cite
APA
Liao, L., Zhang, Z., Li, Z., Wei, D., Xie, Y., Zeng, H., Zhao, H., Zhou, Y., Gu, D., & Duan, X. (2025). The Contradictory Effects of SPTLC1 on Clear Cell Renal Carcinoma Sensitivity to Sunitinib Mediated by Androgen Receptor. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70023
Vancouver
Liao L, Zhang Z, Li Z, Wei D, Xie Y, Zeng H, et al. The Contradictory Effects of SPTLC1 on Clear Cell Renal Carcinoma Sensitivity to Sunitinib Mediated by Androgen Receptor. Molecular Carcinogenesis. 2025. doi:10.1002/mc.70023
BibTeX
@article{Liao2025,
author = {Liao, Liqiong and Zhang, Zhixiong and Li, Zhenhua and Wei, Daqiang and Xie, Yanni and Zeng, Haodong and Zhao, Hongyang and Zhou, Yuhao and Gu, Di and Duan, Xiaolu},
title = {The Contradictory Effects of SPTLC1 on Clear Cell Renal Carcinoma Sensitivity to Sunitinib Mediated by Androgen Receptor},
journal = {Molecular Carcinogenesis},
year = {2025},
doi = {10.1002/mc.70023}
}
EUVIMED